Cargando…

Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain

We previously reported the sequential recovery of daptomycin-nonsusceptible MRSA clinical isolates with an L431F substitution in the MprF protein. The aim of the present study is to determine the effect of this mutation by replacing the mprF gene on the chromosome of a daptomycin-susceptible progeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Feng-Jui, Lauderdale, Tsai-Ling, Lee, Chen-Hsiang, Hsu, Yu-Chieh, Huang, I-Wen, Hsu, Pei-Chi, Yang, Chung-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980971/
https://www.ncbi.nlm.nih.gov/pubmed/29887848
http://dx.doi.org/10.3389/fmicb.2018.01086
_version_ 1783327950973698048
author Chen, Feng-Jui
Lauderdale, Tsai-Ling
Lee, Chen-Hsiang
Hsu, Yu-Chieh
Huang, I-Wen
Hsu, Pei-Chi
Yang, Chung-Shi
author_facet Chen, Feng-Jui
Lauderdale, Tsai-Ling
Lee, Chen-Hsiang
Hsu, Yu-Chieh
Huang, I-Wen
Hsu, Pei-Chi
Yang, Chung-Shi
author_sort Chen, Feng-Jui
collection PubMed
description We previously reported the sequential recovery of daptomycin-nonsusceptible MRSA clinical isolates with an L431F substitution in the MprF protein. The aim of the present study is to determine the effect of this mutation by replacing the mprF gene on the chromosome of a daptomycin-susceptible progenitor strain, CGK5, to obtain CGK5mut having the L431F MprF mutation. Compared to CGK5, the daptomycin and vancomycin MICs of CGK5mut increased from 0.5 to 3 μg/ml and from 1.5 to 3 μg/ml, respectively; however, its oxacillin MIC decreased from 128 to 1 μg/ml in medium without added 2% NaCl. The expression levels of vraSR and several other cell-wall synthesis-related genes were significantly increased in CGK5mut, and the mutant also had significantly reduced negative cell membrane charge, thicker cell wall, and longer doubling time. These features were abolished in the reverse mutant carrying F431L MprF, confirming the pleiotropic effects of the L431F MprF mutation. We believe that this is the first work that shows a single MprF missense mutation can lead to not only changes in the cell membrane but also increased expression of vraSR and subsequently increased resistance to daptomycin and vancomycin while simultaneously conferring increased susceptibility to oxacillin in an isogenic MRSA strain.
format Online
Article
Text
id pubmed-5980971
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59809712018-06-08 Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain Chen, Feng-Jui Lauderdale, Tsai-Ling Lee, Chen-Hsiang Hsu, Yu-Chieh Huang, I-Wen Hsu, Pei-Chi Yang, Chung-Shi Front Microbiol Microbiology We previously reported the sequential recovery of daptomycin-nonsusceptible MRSA clinical isolates with an L431F substitution in the MprF protein. The aim of the present study is to determine the effect of this mutation by replacing the mprF gene on the chromosome of a daptomycin-susceptible progenitor strain, CGK5, to obtain CGK5mut having the L431F MprF mutation. Compared to CGK5, the daptomycin and vancomycin MICs of CGK5mut increased from 0.5 to 3 μg/ml and from 1.5 to 3 μg/ml, respectively; however, its oxacillin MIC decreased from 128 to 1 μg/ml in medium without added 2% NaCl. The expression levels of vraSR and several other cell-wall synthesis-related genes were significantly increased in CGK5mut, and the mutant also had significantly reduced negative cell membrane charge, thicker cell wall, and longer doubling time. These features were abolished in the reverse mutant carrying F431L MprF, confirming the pleiotropic effects of the L431F MprF mutation. We believe that this is the first work that shows a single MprF missense mutation can lead to not only changes in the cell membrane but also increased expression of vraSR and subsequently increased resistance to daptomycin and vancomycin while simultaneously conferring increased susceptibility to oxacillin in an isogenic MRSA strain. Frontiers Media S.A. 2018-05-25 /pmc/articles/PMC5980971/ /pubmed/29887848 http://dx.doi.org/10.3389/fmicb.2018.01086 Text en Copyright © 2018 Chen, Lauderdale, Lee, Hsu, Huang, Hsu and Yang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Chen, Feng-Jui
Lauderdale, Tsai-Ling
Lee, Chen-Hsiang
Hsu, Yu-Chieh
Huang, I-Wen
Hsu, Pei-Chi
Yang, Chung-Shi
Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
title Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
title_full Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
title_fullStr Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
title_full_unstemmed Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
title_short Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
title_sort effect of a point mutation in mprf on susceptibility to daptomycin, vancomycin, and oxacillin in an mrsa clinical strain
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980971/
https://www.ncbi.nlm.nih.gov/pubmed/29887848
http://dx.doi.org/10.3389/fmicb.2018.01086
work_keys_str_mv AT chenfengjui effectofapointmutationinmprfonsusceptibilitytodaptomycinvancomycinandoxacillininanmrsaclinicalstrain
AT lauderdaletsailing effectofapointmutationinmprfonsusceptibilitytodaptomycinvancomycinandoxacillininanmrsaclinicalstrain
AT leechenhsiang effectofapointmutationinmprfonsusceptibilitytodaptomycinvancomycinandoxacillininanmrsaclinicalstrain
AT hsuyuchieh effectofapointmutationinmprfonsusceptibilitytodaptomycinvancomycinandoxacillininanmrsaclinicalstrain
AT huangiwen effectofapointmutationinmprfonsusceptibilitytodaptomycinvancomycinandoxacillininanmrsaclinicalstrain
AT hsupeichi effectofapointmutationinmprfonsusceptibilitytodaptomycinvancomycinandoxacillininanmrsaclinicalstrain
AT yangchungshi effectofapointmutationinmprfonsusceptibilitytodaptomycinvancomycinandoxacillininanmrsaclinicalstrain